AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
AtriCure(ATRC) Zacks Investment Research·2024-05-02 06:31
AtriCure (ATRC) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -19.05%. A quarter ago, it was expected that this medical device maker would post a loss of $0.22 per share when it actually produced a loss of $0.21, delivering a surprise of 4.55%.Over the last four quarters, the company has su ...